NGL Fine-Chem Limited Recommends Final Dividend for the Financial Year Ended on March 31, 2023, Payable on or After September 4, 2023
May 15, 2023 at 08:55 am EDT
Share
NGL Fine-Chem Limited at its board meeting held on May 15, 2023, approved recommendation of final Dividend of INR 1.75 per fully paid up equity share of INR 5 each for the financial year ended on March 31, 2023. The Record date for the purpose of payment of final dividend is August 18, 2023. The dividend, if declared at the AGM to be held on August 25, 2023, will be paid on or after September 4, 2023.
NGL Fine-Chem Limited is an India-based company, which is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health. The Company caters to various global companies to custom manufacture pharmaceuticals. Its products include APIs Animal Health, APIs Human Health, Intermediates and Specialty Chemicals and Finished Dosage Form. The APIs Animal Health products include Homidium Chloride, Nitroxynil, Clorsulon, Parvaquone, Buparvaquone, Isometamidium Chloride Hydrochloride, Toldimfos Sodium, Butaphosphan, Imidocarb Dipropionate, Triclabendazole, Rafoxanide, Diminazene Aceturate, S-Methoprene, Carprofen and others. The APIs Human Health products include Nitazoxanide and Atovaquone. The Intermediates and Specialty Chemicals product includes 1,4,7-Trimethyl-1,4,7-Triazacylononane and N-Ethyl Glucamine. The Finished Dosage Form products include Diminazene Aceturate Granules and Homidium Chloride Tablets. It has manufacturing plants located around Mumbai.